Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing

Edgar Argulian, Jose Ricardo F. Po, Seth Uretsky, Kiran K. Kommaraju, Suketukumar Patel, Vikram Agarwal, Randy Cohen, Alan Rozanski

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Symptom-limited exercise is the preferred method of cardiac stress testing, but pharmacologic testing has been increasing over time. The exact reasons for pharmacologic stress testing have not been rigorously categorized. Thus, we systematically explored the reasons for pharmacologic stress testing in patients referred for cardiac stress imaging. Methods: We studied consecutive patients referred for stress imaging [stress echocardiography or radionuclide myocardial perfusion imaging (MPI)] at Mount Sinai St Luke’s hospital between August 2013 and April 2014. Baseline information was obtained using a standardized questionnaire and a trained physician triaged the patient for symptom-limited exercise stress testing or pharmacologic stress testing. Results: In total, 551(48%) of our entire stress cohort underwent cardiac imaging following initial exercise testing and 589 (52%) underwent imaging with initial pharmacologic stress testing. Deconditioning and inability to walk (primarily due to musculoskeletal conditions) constituted the top two reasons for performing pharmacologic stress, followed by frailty, left bundle branch block (for MPI), resting wall motion abnormality (for echocardiography), and failed exercise attempts. The reasons for performing pharmacologic stress testing were similar in the MPI and echocardiography patients, despite a much higher level of disease acuity in the MPI group. Conclusions: We have applied a systematic approach for categorizing the reasons for pharmacologic stress. These reasons are heterogeneous, but similar across MPI and echo stress laboratories.

Original languageEnglish (US)
Pages (from-to)546-554
Number of pages9
JournalJournal of Nuclear Cardiology
Volume24
Issue number2
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Myocardial Perfusion Imaging
Radioisotopes
Exercise
Echocardiography
Stress Echocardiography
Bundle-Branch Block
Physicians

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Argulian, Edgar ; Po, Jose Ricardo F. ; Uretsky, Seth ; Kommaraju, Kiran K. ; Patel, Suketukumar ; Agarwal, Vikram ; Cohen, Randy ; Rozanski, Alan. / Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing. In: Journal of Nuclear Cardiology. 2017 ; Vol. 24, No. 2. pp. 546-554.
@article{b31f4864321a49f4b90c2b5d013249b4,
title = "Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing",
abstract = "Background: Symptom-limited exercise is the preferred method of cardiac stress testing, but pharmacologic testing has been increasing over time. The exact reasons for pharmacologic stress testing have not been rigorously categorized. Thus, we systematically explored the reasons for pharmacologic stress testing in patients referred for cardiac stress imaging. Methods: We studied consecutive patients referred for stress imaging [stress echocardiography or radionuclide myocardial perfusion imaging (MPI)] at Mount Sinai St Luke’s hospital between August 2013 and April 2014. Baseline information was obtained using a standardized questionnaire and a trained physician triaged the patient for symptom-limited exercise stress testing or pharmacologic stress testing. Results: In total, 551(48{\%}) of our entire stress cohort underwent cardiac imaging following initial exercise testing and 589 (52{\%}) underwent imaging with initial pharmacologic stress testing. Deconditioning and inability to walk (primarily due to musculoskeletal conditions) constituted the top two reasons for performing pharmacologic stress, followed by frailty, left bundle branch block (for MPI), resting wall motion abnormality (for echocardiography), and failed exercise attempts. The reasons for performing pharmacologic stress testing were similar in the MPI and echocardiography patients, despite a much higher level of disease acuity in the MPI group. Conclusions: We have applied a systematic approach for categorizing the reasons for pharmacologic stress. These reasons are heterogeneous, but similar across MPI and echo stress laboratories.",
author = "Edgar Argulian and Po, {Jose Ricardo F.} and Seth Uretsky and Kommaraju, {Kiran K.} and Suketukumar Patel and Vikram Agarwal and Randy Cohen and Alan Rozanski",
year = "2017",
month = "4",
day = "1",
doi = "10.1007/s12350-016-0398-2",
language = "English (US)",
volume = "24",
pages = "546--554",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "2",

}

Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing. / Argulian, Edgar; Po, Jose Ricardo F.; Uretsky, Seth; Kommaraju, Kiran K.; Patel, Suketukumar; Agarwal, Vikram; Cohen, Randy; Rozanski, Alan.

In: Journal of Nuclear Cardiology, Vol. 24, No. 2, 01.04.2017, p. 546-554.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing

AU - Argulian, Edgar

AU - Po, Jose Ricardo F.

AU - Uretsky, Seth

AU - Kommaraju, Kiran K.

AU - Patel, Suketukumar

AU - Agarwal, Vikram

AU - Cohen, Randy

AU - Rozanski, Alan

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Background: Symptom-limited exercise is the preferred method of cardiac stress testing, but pharmacologic testing has been increasing over time. The exact reasons for pharmacologic stress testing have not been rigorously categorized. Thus, we systematically explored the reasons for pharmacologic stress testing in patients referred for cardiac stress imaging. Methods: We studied consecutive patients referred for stress imaging [stress echocardiography or radionuclide myocardial perfusion imaging (MPI)] at Mount Sinai St Luke’s hospital between August 2013 and April 2014. Baseline information was obtained using a standardized questionnaire and a trained physician triaged the patient for symptom-limited exercise stress testing or pharmacologic stress testing. Results: In total, 551(48%) of our entire stress cohort underwent cardiac imaging following initial exercise testing and 589 (52%) underwent imaging with initial pharmacologic stress testing. Deconditioning and inability to walk (primarily due to musculoskeletal conditions) constituted the top two reasons for performing pharmacologic stress, followed by frailty, left bundle branch block (for MPI), resting wall motion abnormality (for echocardiography), and failed exercise attempts. The reasons for performing pharmacologic stress testing were similar in the MPI and echocardiography patients, despite a much higher level of disease acuity in the MPI group. Conclusions: We have applied a systematic approach for categorizing the reasons for pharmacologic stress. These reasons are heterogeneous, but similar across MPI and echo stress laboratories.

AB - Background: Symptom-limited exercise is the preferred method of cardiac stress testing, but pharmacologic testing has been increasing over time. The exact reasons for pharmacologic stress testing have not been rigorously categorized. Thus, we systematically explored the reasons for pharmacologic stress testing in patients referred for cardiac stress imaging. Methods: We studied consecutive patients referred for stress imaging [stress echocardiography or radionuclide myocardial perfusion imaging (MPI)] at Mount Sinai St Luke’s hospital between August 2013 and April 2014. Baseline information was obtained using a standardized questionnaire and a trained physician triaged the patient for symptom-limited exercise stress testing or pharmacologic stress testing. Results: In total, 551(48%) of our entire stress cohort underwent cardiac imaging following initial exercise testing and 589 (52%) underwent imaging with initial pharmacologic stress testing. Deconditioning and inability to walk (primarily due to musculoskeletal conditions) constituted the top two reasons for performing pharmacologic stress, followed by frailty, left bundle branch block (for MPI), resting wall motion abnormality (for echocardiography), and failed exercise attempts. The reasons for performing pharmacologic stress testing were similar in the MPI and echocardiography patients, despite a much higher level of disease acuity in the MPI group. Conclusions: We have applied a systematic approach for categorizing the reasons for pharmacologic stress. These reasons are heterogeneous, but similar across MPI and echo stress laboratories.

UR - http://www.scopus.com/inward/record.url?scp=84959147235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959147235&partnerID=8YFLogxK

U2 - 10.1007/s12350-016-0398-2

DO - 10.1007/s12350-016-0398-2

M3 - Article

C2 - 26911366

AN - SCOPUS:84959147235

VL - 24

SP - 546

EP - 554

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

IS - 2

ER -